These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8049 related articles for article (PubMed ID: 14708716)

  • 21. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition.
    Riteau B; Menier C; Khalil-Daher I; Martinozzi S; Pla M; Dausset J; Carosella ED; Rouas-Freiss N
    Int Immunol; 2001 Feb; 13(2):193-201. PubMed ID: 11157852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered expression of nonclassical HLA class Ib antigens in human renal cell carcinoma and its association with impaired immune response.
    Bukur J; Malenica B; Huber C; Seliger B
    Hum Immunol; 2003 Nov; 64(11):1081-92. PubMed ID: 14602239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-G in cancer: a way to turn off the immune system.
    Rouas-Freiss N; Moreau P; Menier C; Carosella ED
    Semin Cancer Biol; 2003 Oct; 13(5):325-36. PubMed ID: 14708712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.
    Kovalcsik E; John J; Turner M; Birchall L; Sage D; Whittle R; Dalgleish A; Pandha H
    Melanoma Res; 2004 Dec; 14(6):463-71. PubMed ID: 15577316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma.
    Kleinberg L; Flørenes VA; Skrede M; Dong HP; Nielsen S; McMaster MT; Nesland JM; Shih IeM; Davidson B
    Virchows Arch; 2006 Jul; 449(1):31-9. PubMed ID: 16541284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.
    Cabrera T; Lara E; Romero JM; Maleno I; Real LM; Ruiz-Cabello F; Valero P; Camacho FM; Garrido F
    Cancer Immunol Immunother; 2007 May; 56(5):709-17. PubMed ID: 16960691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uveal melanoma: no expression of HLA-G.
    Hurks HM; Valter MM; Wilson L; Hilgert I; van den Elsen PJ; Jager MJ
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3081-4. PubMed ID: 11726606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.
    Wiendl H; Mitsdoerffer M; Hofmeister V; Wischhusen J; Bornemann A; Meyermann R; Weiss EH; Melms A; Weller M
    J Immunol; 2002 May; 168(9):4772-80. PubMed ID: 11971028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
    del Campo AB; Kyte JA; Carretero J; Zinchencko S; Méndez R; González-Aseguinolaza G; Ruiz-Cabello F; Aamdal S; Gaudernack G; Garrido F; Aptsiauri N
    Int J Cancer; 2014 Jan; 134(1):102-13. PubMed ID: 23784959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-G in skin cancer: a wolf in sheep's clothing?
    Urosevic M; Dummer R
    Hum Immunol; 2003 Nov; 64(11):1073-80. PubMed ID: 14602238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
    Menier C; Riteau B; Carosella ED; Rouas-Freiss N
    Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.
    Ibrahim EC; Aractingi S; Allory Y; Borrini F; Dupuy A; Duvillard P; Carosella ED; Avril MF; Paul P
    Int J Cancer; 2004 Jan; 108(2):243-50. PubMed ID: 14639610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human leukocyte antigen G expression in breast cancer: role in immunosuppression.
    Elliott RL; Jiang XP; Phillips JT; Barnett BG; Head JF
    Cancer Biother Radiopharm; 2011 Apr; 26(2):153-7. PubMed ID: 21510769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of HLA-G expression.
    Polakova K; Bandzuchova E; Tirpakova J; Kuba D; Russ G
    Neoplasma; 2007; 54(6):455-62. PubMed ID: 17949227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of human leukocyte antigen-G on trophoblasts abolishes the growth-suppressing effect of interleukin-2 towards them.
    Hamai Y; Fujii T; Yamashita T; Miki A; Hyodo H; Kozuma S; Geraghty DE; Taketani Y
    Am J Reprod Immunol; 1999 Feb; 41(2):153-8. PubMed ID: 10102086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
    Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
    Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted.
    Poláková K; Russ G
    Neoplasma; 2000; 47(6):342-8. PubMed ID: 11263857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-G and lymphoproliferative disorders.
    Amiot L; Le Friec G; Sebti Y; Drénou B; Pangault C; Guilloux V; Leleu X; Bernard M; Facon T; Fauchet R
    Semin Cancer Biol; 2003 Oct; 13(5):379-85. PubMed ID: 14708718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
    Rouas-Freiss N; Moreau P; Ferrone S; Carosella ED
    Cancer Res; 2005 Nov; 65(22):10139-44. PubMed ID: 16287995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 403.